FeesSafety
Pluang+

CNX Resources reports Q3 2026 financial results and operational updates, emphasizing low-carbon natural gas production.

Company Fundamentals
29 Oct 2026, 13:45 WIB
PRNewsWire
View Source
Neutral
CNX Resources reports Q3 2026 financial results and operational updates, emphasizing low-carbon natural gas production.

CNX Resources Corporation released its financial and operational results for the third quarter of 2026, highlighting its focus on ultra-low carbon natural gas development in Appalachia. The company provided detailed earnings, production volumes, hedging information, and financial statements on its website. CNX continues to leverage its 162-year legacy and substantial reserves to create long-term value for shareholders and communities. Investors can access the company's prepared remarks and participate in a Q&A conference call for further insights.

CNX Resources Corporation's third quarter results provide context for energy market watchers. For readers following the energy sector, here is Pluang's market snapshot as of Oct 29, 2026 17:41 WIB: Among 79 priced US energy stocks, 54 rose and 21 fell today. Notable movers include INDO at USD 2.73 with a 1-day change of +2.25% and 100% buy order activity, LEU at USD 109.57 down 2.14% with 66% sell orders, and UEC at USD 8.17 down 2.10% with 75% buy orders.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App